Xencor (XNCR) - P/S ratio

P/S ratio as of October 2026 (TTM): 20.5

According to Xencor's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.27. At the end of 2026 the company had a P/S ratio of 10.6.

P/S ratio history for Xencor from 2013 to 2026

PS ratio at the end of each year

Year	P/S ratio	Change
2026	10.6	25.28%
2025	8.48	-36.25%
2024	13.3	73.36%
2023	7.68	-19.03%
2022	9.48	11.17%
2021	8.53	-58.26%
2020	20.4	63.61%
2019	12.5	-75.08%
2018	50.1	31.17%
2017	38.2	173.76%
2016	14.0	-34.64%
2015	21.4	-59.68%
2014	53.0	87.99%
2013	28.2

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Johnson & Johnson JNJ	6.76	-66.99%	🇺🇸 USA
AbbVie ABBV	8.08	-60.53%	🇺🇸 USA
Amgen AMGN	6.62	-67.64%	🇺🇸 USA
Merck MRK	5.56	-72.85%	🇺🇸 USA
Seagen SGEN	18.8	-8.32%	🇺🇸 USA
MacroGenics MGNX	0.9118	-95.54%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Xencor (XNCR)

P/S ratio as of October 2026 (TTM): 20.5